biOasis Technologies Ord Shs V.BTI.H

Tough time in the market now...

[prophetoffactz]

The market is struggling with inflation concerns again. The S&P Biotech ETF had a strong move into the new year but has collapsed back to where it was when BTI was closing the Biodexa deal. Protalix got close to reaching its 52-week high today despite the market on the recommendation for approval.

[Boomskid]

Lol, poof, when you're pushed back onto your hind feet, you want to talk about how "The S&P Biotech ETF had a strong move into the new year but has collapsed back to where it was when BTI was closing the Biodexa deal." So, Bioasis is at 1.5¢ today because of inflation and because of the market that has pushed the S&P Biotech ETF down? Is that it? You don't

[prophetoffactz]

When 25% of biotech in general and even moreso preclinical biotech was driven below the value of cash on the balance sheet in the worst bear market in history it wasn't caused by Rathjen. Your happy talk about a preclinical biotech taking on debt before the worst biotech bear market in history was not helpful; especially given BTI was still transitioning to find a new horse after all of your

[Boomskid]

The Bioasis share price of 1.5¢ was not caused by the market nonsense you describe, poof. The S&P ETFs are not down 95% over the last 4 years like Bioasis is. You and Bioasis seem to think that Bioasis shareholders will believe anything just because you said so.  Got news for you and Bioasis, poof. The shareholders have it all figured out. They believe that Bioasis has been almost

[zwerp2000]

LOL, as i said to you before, prophetofabsurdity, a few years ago, the biotech market was incredibly hot. companies, big and small, were flying higher. there was one lucrative deal after another. but guess what, bti's stock continued to languish. bti still could not get a deal even though big pharma/biotech were handing out money to small companies like candy. another sorry excuse